Compare eBay Inc (EBAY) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Sana Biotechnology Inc — how do they compare? eBay Inc trades at $111.48 (market cap $50.07B), while Sana Biotechnology Inc trades at $3.2 (market cap $987.94M). The key difference: eBay Inc is far larger — about 50.7× Sana Biotechnology Inc's market cap, and eBay Inc pays a 1.1% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| EBAY | SANA | |
|---|---|---|
Market Cap | $50.07B | $987.94M |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $5.92 |
52-Week Low | $76.79 | $2.68 |
Enterprise Value | $53.41B | $962.13M |
Dividend Yield | 1.1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.48, down 0.94% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported revenue of $11.10B in 2025 with a net income margin of 17.61%, and has beaten EPS estimates for three consecutive quarters. Recent news highlights eBay's cleared acquisition of Depop and ongoing takeover interest from GameStop.
EBAY presents a mixed outlook with strong profitability and consistent earnings beats offset by high valuation multiples and competitive pressures. The stock's upside potential hinges on successful integration of acquisitions and advertising growth, while risks include market volatility and execution challenges in a dynamic e-commerce landscape.
Sana Biotechnology (SANA) trades at $3.225, down 9.66% on the day, reflecting market volatility despite a bullish technical signal and strong analyst support. The company shows significant financial losses with a -$244.17M net income for 2025 and negative cash flows, but has beaten earnings expectations in two of the last three quarters. Recent news highlights clinical progress in cell therapies and a $69M capital raise via an ATM facility in May 2026.
The investment case balances high-risk fundamentals against promising clinical developments and overwhelming analyst optimism. While substantial losses and cash burn present clear risks, the company's scientific advancements and 82% buy rating from analysts suggest potential long-term upside for risk-tolerant investors in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
